Background-Electrophysiological mechanisms by which adenosine may activate cardiac afferent neurons are unknown.
A denosine is an endogenous nucleoside generated from the breakdown of ATP during myocardial ischemia. Most [1] [2] [3] [4] [5] but not all 6, 7 experimental evidence in animals and humans suggests that adenosine released in the ischemic myocardium acts on cardiac afferent neurons to initiate systemic reflexes and to mediate cardiac pain. Thames and colleagues 1 reported that myocardial ischemia in dogs reflexly increased renal sympathetic nerve activity. Sympathetic excitation was blunted in the presence of the adenosine antagonist aminophylline and augmented by dipyridamole, an inhibitor of adenosine uptake and elimination. In further experiments, an A 1 -receptor-selective agonist but not an A 2 -receptor-selective agonist reproduced the reflex sympathetic excitation. 2 Transection of cardiac sympathetic afferent neurons eliminated this reflex increase in renal sympathetic nerve activity. These findings are consistent with activation of A 1 -adenosine receptors on sympathetic afferent neurons in the heart as mediators of reflex sympathetic excitation. In humans, intracoronary adenosine reproduces angina-like chest pain in the absence of ischemia. 3 Intracoronary adenosine induces a reflex increase in blood pressure and plasma catecholamines. 4 Chest pain during adenosine infusion or during exercise testing is decreased by infusion of aminophylline. 3 On the other hand, an adenosine analogue administered intra-arterially to anesthetized cats had little if any effect on afferent nerve activity. 6 In patch-clamping experiments, adenosine administered to rat nodose ganglion cells (cell body of vagal afferent neurons) does not elicit spontaneous action potentials. 7 The cellular electrophysiological mechanisms by which adenosine may activate cardiac afferent neurons to initiate systemic reflexes and elicit cardiac pain are unknown. Slow afterhyperpolarizations (AHPs) follow action potentials in a subset of vagal C afferent neurons, rendering them inexcitable. Attenuation of these slow AHPs increases neuronal excitability. 8 -10 Slow AHPs are mediated by I K(Ca) and are suppressed by cAMP. 8 We have previously reported that adenosine, working on A 1 -adenosine receptors, attenuates the voltage-dependent I Ca on a subset of cardiac vagal afferent neurons in rats. 7 Therefore, we postulated that adenosine A 1 -receptor activation may be neuroexcitatory by suppressing increases in intracellular calcium, thereby decreasing slow AHP amplitude. Alternatively, activation of A 2 receptors increases cAMP, which directly inhibits slow AHPs. The purpose of this study was to test the hypothesis that adenosine increases vagal neuronal excitability by blocking slow AHPs, to identify the adenosine receptor subtype mediating these effects, and to determine whether the underlying mechanism is mediated by suppression of calcium currents or cAMP.
Methods

Tissue Culture
Nodose ganglia from adult New Zealand White rabbits were isolated. Tissue culture was performed according to the method of Yoshimura et al. 11 Cells were used for electrophysiological studies within 24 hours after isolation. . Adenosine (10 mol/L) reversibly increases action potential response rate. A, Cell was stimulated at 20% threshold at 100-ms interspike intervals. At baseline, first 6 stimuli elicited action potentials, followed by hyperpolarization of cell membrane and failure to capture. B, In same cell, about 1 minute into adenosine (10 mol/L) administration, 11 action potentials are elicited at beginning of train. Slow AHP is smaller and 6 more stimuli are followed by action potentials. C, Approximately 3 minutes into adenosine administration, slow AHP has been eliminated and there is 100% response rate to stimulus train. D, Approximately 2 minutes after washout of adenosine in same cell, first 8 stimuli elicited action potentials, followed by slow AHP and failure to capture. Dashed lines in each panel (labeled AP) show V max of action potentials. E, Baseline action potential response rate was 3.8Ϯ0.5%, which, after adenosine, increased to 28Ϯ7% (Pϭ0.0009) and during washout returned to baseline levels (5Ϯ1%, PϭNS). Note degree of augmentation was variable. Lines connect responses of individual neurons, open circles indicate meanϮSD. Forskolin (10 mol/L) and cadmium (0.01 mmol/L) reversibly increase action potential response rate. Left, Baseline action potential response rate was 5Ϯ1.2%, which, after forskolin, increased to 41Ϯ17% (Pϭ0.05) and then during washout returned to baseline levels (8.5Ϯ5%, PϭNS). Right, Baseline action potential response rate was 4.4Ϯ0.9%, which, after cadmium, increased to 68Ϯ17% (Pϭ0.01) and during washout returned to baseline levels (4.6Ϯ1%, PϭNS). Patch was lost in some cells before washout data could be obtained.
Cellular Electrophysiology
and CaCl 2 was increased to 5 mmol/L; in the internal solution, K was replaced with 30 mmol/L tetraethylammonium (TEA) and 110 mmol/L Cs. Amphotericin (240 mg/mL) was used to perforate the cell membrane, as described previously. 12 In current-clamp mode, action potentials were stimulated by current injection, and cells with slow AHPs were identified. Trains of 100 current pulses were injected at 20% above threshold, with an interspike interval of 100 ms. The number of action potentials elicited by the train was counted as a measure of excitability and reported as the action potential response rate. In voltage-clamp experiments, calcium currents were elicited by depolarizing voltage steps from a holding potential of Ϫ80 mV after blocking TTX-sensitive Na currents and K currents. Solution changes were performed with the aid of a rapid extracellular solution-exchange device. This system permits Ͼ90% exchange of the bath surrounding the neuron in Ͻ1 second.
Statistical Analysis
Data were analyzed by paired t tests and ANOVA.
Results
Effects of Adenosine on Action Potentials
The purpose of these experiments was (1) to determine if adenosine inhibited slow AHPs and increased vagal afferent excitability and (2) to determine if these slow AHPs were sensitive to forskolin (which augments cAMP) and/or cadmium (nonspecific I Ca inhibitor) (Figure 1) . A total of 18 cells with slow AHPs and 10 cells without slow AHPs were studied. During adenosine (10 mol/L) administration, slow AHPs were suppressed, and the action potential response rate was augmented from 3.8Ϯ0.5% at baseline to 28Ϯ7% after adenosine (Pϭ0.0009). Inhibition of slow AHPs and increased action potential response rate took several minutes to develop and largely reversed within 3 minutes of discontinuing adenosine (Figure 1) . Although the action potential response rate was augmented by Ն10% in 17 of 18 cells, the degree of augmentation was variable (Figure 1 ), as has generally been observed in electrophysiological responses in this type of preparation. 9, 10 Adenosine had no effect on action potential response rate in cells without slow AHPs (data not shown).
Slow AHPs were reversibly inhibited by forskolin (10 mol/L), resulting in an increased action potential response rate from 5Ϯ1.2% at baseline to 41Ϯ17% after forskolin, (nϭ5, Pϭ0.05) (Figure 2A ). Slow AHPs were also suppressed when cadmium (Cd, 0.1 mmol/L) was used to block the calcium current, resulting in an increased action potential response rate from 4.4Ϯ0.9% at baseline to 68Ϯ17% after Cd (nϭ6, Pϭ0.01) ( Figure 2B ). Cd inhibition of slow AHPs was fully reversible.
Adenosine Receptor Subtype
To determine the adenosine receptor subtype responsible for blocking the slow AHPs, the adenosine A 1 -receptor agonist 2-chloro-N6-cyclopentyladenosine (CCPA,100 nmol/L) was administered to 7 cells with slow AHPs. After 3 minutes of exposure to CCPA, there was no detectable attenuation of slow AHPs or significant increase in action potential response rate (4.4Ϯ2.6% versus 9.7Ϯ4.5%, PϭNS) (Figure 3) .
In 8 cells with slow AHPs, adenosine was administered in the presence of the selective A 1 -receptor blocker 8-cyclopentyl-1,3-dipropylxanthine (DPCPX, 5 mol/L). Slow AHPs and action potential response rate remained similar to the response rate in the presence of adenosine alone in the same neurons (Figure 4) .
The adenosine A 2 -receptor agonist 5Ј-(N-ethylcarboxamido) adenosine (NECA, 10 mol/L) was administered to 4 cells with slow AHPs. NECA decreased the delayed AHP amplitude and increased action potential response rate( Figure  5) , with a similar time course as adenosine from 2.8Ϯ0.9% at baseline to 37Ϯ11% after NECA (Pϭ0.02). This increased excitability was reversible (washout rate, 4.8Ϯ1.1%).
In 6 response rate induced by adenosine in these cells was abolished in the presence of ZM 241385 ( Figure 6 ).
Effects of Adenosine on I Ca
To determine if adenosine partially blocked I Ca in rabbit vagal afferent neurons, as we reported previously in rat vagal afferent neurons, 7 a total of 20 cells were studied in the whole-cell voltage-clamp mode. I Ca was completely blocked by the nonspecific I Ca blocker Cd (0.1 mm), but adenosine did not inhibit inward I Ca in 20 cells tested (Figure 7 ).
Discussion
The major findings of this study are (1) adenosine blocks slow AHPs when they are present on vagal afferent neurons, markedly enhancing excitability; (2) this effect is mediated through the adenosine A 2A receptor; and (3) in rabbit nodose ganglion cells studied here, in contrast to rat nodose ganglion cells, adenosine does not inhibit I Ca . The likely mechanism by which slow AHPs are suppressed is through enhanced cAMP production after A 2A receptor stimulation rather than suppression of I Ca .
During muscle ischemia, a number of compounds are released that have been shown to be neuroexcitatory in afferent neurons, including lactic acid, arachidonic acid, and potassium ions. 6, 13 When adenosine is administered directly to isolated sensory neurons, it does not stimulate action potentials. 6, 7 Our results help clarify adenosine's role as a neuroexcitatory agent. Adenosine does not appear to directly trigger neuroexcitation but by attenuating slow AHPs enables vagal afferent neurons to fire rapidly and repeatedly in the presence of other neuroexcitatory stimulants. Therefore, during muscle ischemia, when many neuroexcitatory compounds are released, adenosine may facilitate expression of this neuroexcitation.
In rabbit nodose ganglion cells, this neuroexcitatory role appears to be mediated by the adenosine A 2A receptor. NECA, a selective A 2 -receptor agonist, reproduced the effects of adenosine, whereas CCPA, a selective adenosine A 1 agonist, did not. In addition, the selective A 2A -adenosine antagonist ZM 241385 but not the A 1 -adenosine antagonist DPCPX abolished augmentation by adenosine of the action potential response rate. In these experiments, our findings suggest that the most likely mechanism by which adenosine attenuates the delayed AHP is through an increase in cAMP. Adenosine A 2A receptors have been shown to increase cAMP through adenylate cyclase, whereas adenosine A 1 receptors inhibit adenylate cyclase. 14 Slow AHPs present on hippocampal CA3 neurons and on nodose ganglion neurons are directly inhibited by cAMP, 8, 15 which we confirmed in our preparation with forskolin, a direct activator of adenylate cyclase. Forskolin both attenuated slow AHPs and augmented action potential response rate. 8 An alternative mechanism for enhanced neuroexcitability is suppression of I Ca by adenosine, leading to a smaller rise in intracellular calcium during stimulation, less activation of I K(Ca) , and suppression of the slow AHP. We showed that this mechanism is generally plausible by blocking I Ca with cadmium, which suppressed slow AHPs and enhanced excitability as postulated. However, in the rabbit nodose ganglion cells, adenosine had no effect on I Ca , eliminating this as a possible contributing mechanism. This contrasts with our previous observations in rat nodose ganglion cells, in which adenosine inhibited I Ca by 50% in approximately two thirds of cells. Interestingly, rat nodose ganglion cells do not exhibit slow AHPs, so other mechanisms of enhancing neuroexcitability may be important.
Limitations
Because adenosine had no effect on I Ca , our findings imply by exclusion that adenosine eliminates slow AHPs by increasing cAMP, consistent with the properties of adenosine A 2A receptors, which are coupled positively to cAMP production. Further studies are needed to directly test this hypothesis and to determine whether the effects of cAMP are mediated by protein kinase A or other cAMP-dependent signaling pathways. These investigations are currently ongoing in our laboratory. Because slow AHPs have been detected in a substantial proportion of vagal afferent neurons in several but not all species, the direct relevance of this work to humans, in whom the proportion of vagal afferents that have slow AHPs is unknown, remains to be determined.
Summary and Implications
These data are consistent with a neuroexcitatory role for adenosine, acting on the adenosine A 2A receptor in rabbit nodose ganglion cells. Vagal afferent neurons modulate ischemic pain, including ischemic cardiac pain, as well as mediate systemic reflexes. 16 Our findings may have implications for understanding the pathophysiology of mechanisms of pain during cardiac ischemia. It is unknown if adenosine has similar neuroexcitatory effects on sympathetic afferent neurons, but these studies are ongoing in our laboratory.
